...
首页> 外文期刊>Biopharmaceutics and Drug Disposition >Identification of CYP isozymes involved in benzbromarone metabolism in human liver microsomes
【24h】

Identification of CYP isozymes involved in benzbromarone metabolism in human liver microsomes

机译:CYP同工酶在人肝微粒体中参与苯溴马隆代谢的鉴定

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Benzbromarone (BBR) is metabolized to 1'-hydroxy BBR and 6-hydroxy BBR in the liver. 6-Hydroxy BBR is further metabolized to 5,6-dihydroxy BBR. The aim of this study was to identify the CYP isozymes involved in the metabolism of BBR to 1'-hydroxy BBR and 6-hydroxy BBR and in the metabolism of 6-hydroxy BBR to 5,6-dihydroxy BBR in human liver microsomes. Among 11 recombinant P450 isozymes examined, CYP3A4 showed the highest formation rate of 1'-hydroxy BBR. The formation rate of 1'-hydroxy BBR significantly correlated with testosterone 6β-hydroxylation activity in a panel of 12 human liver microsomes. The formation of 1'-hydroxy BBR was completely inhibited by ketoconazole in pooled human liver microsomes. On the other hand, the highest formation rate of 6-hydroxy BBR was found in recombinant CYP2C9. The highest correlation was observed between the formation rate of 6-hydroxy BBR and diclofenac 4'-hydroxylation activity in 12 human liver microsomes. The formation of 6-hydroxy BBR was inhibited by tienilic acid in pooled human liver microsomes. The formation of 5,6-dihydroxy BBR from 6-hydroxy BBR was catalysed by recombinant CYP2C9 and CYP1A2. The formation rate of 5,6-dihydroxy BBR was significantly correlated with diclofenac 4'-hydroxylation activity and phenacetin O-deethylation activity in 12 human liver microsomes. The formation of 5,6-dihydroxy BBR was inhibited with either tienilic acid or α-naphthoflavone in human liver microsomes. These results suggest that (i) the formation of 1'-hydroxy BBR and 6-hydroxy BBR is mainly catalysed by CYP3A4 and CYP2C9, respectively, and (ii) the formation of 5,6-dihydroxy BBR is catalysed by CYP2C9 and CYP1A2 in human liver microsomes.
机译:苯溴马隆(BBR)在肝脏中代谢为1'-羟基BBR和6-羟基BBR。将6-羟基BBR进一步代谢为5,6-二羟基BBR。这项研究的目的是确定在人肝微粒体中BBR代谢为1'-羟基BBR和6-羟基BBR以及6-羟基BBR代谢为5,6-二羟基BBR的CYP同工酶。在检查的11种重组P450同工酶中,CYP3A4的1'-羟基BBR形成率最高。在一组12个人肝微粒体中,1'-羟基BBR的形成速率与睾丸激素6β-羟基化活性显着相关。合并的人肝微粒体中的酮康唑完全抑制了1'-羟基BBR的形成。另一方面,在重组CYP2C9中发现6-羟基BBR的最高形成速率。在12个人肝微粒体中,6-羟基BBR的形成速率与双氯芬酸4'-羟基化活性之间的相关性最高。亚硝酸在合并的人肝微粒体中抑制了6-羟基BBR的形成。重组CYP2C9和CYP1A2催化从6-羟基BBR形成5,6-二羟基BBR。在12个人肝微粒体中,5,6-二羟基BBR的形成速率与双氯芬酸4'-羟基化活性和非那西丁O-脱乙基活性显着相关。在人肝微粒体中,亚铁酸或α-萘黄酮均可抑制5,6-二羟基BBR的形成。这些结果表明(i)1'-羟基BBR和6-羟基BBR的形成分别主要由CYP3A4和CYP2C9催化,(ii)5,6-二羟基BBR的形成由CYP2C9和CYP1A2催化。人肝微粒体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号